Free Trial

Bio-Rad Laboratories (BIO.B) Competitors

Bio-Rad Laboratories logo
$247.05 0.00 (0.00%)
As of 09/15/2025

BIO.B vs. VLTO, TER, FTV, RVTY, AVTR, NVMI, VNT, MIR, RAL, and ST

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Veralto (VLTO), Teradyne (TER), Fortive (FTV), Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Vontier (VNT), Mirion Technologies (MIR), Ralliant (RAL), and Sensata Technologies (ST). These companies are all part of the "measuring and control equipment" industry.

Bio-Rad Laboratories vs. Its Competitors

Bio-Rad Laboratories (NYSE:BIO.B) and Veralto (NYSE:VLTO) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 91.3% of Veralto shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 0.4% of Veralto shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Veralto has a consensus price target of $113.43, suggesting a potential upside of 6.48%. Given Veralto's stronger consensus rating and higher possible upside, analysts plainly believe Veralto is more favorable than Bio-Rad Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Veralto
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56

Bio-Rad Laboratories has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Veralto has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.

In the previous week, Veralto had 15 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 16 mentions for Veralto and 1 mentions for Bio-Rad Laboratories. Veralto's average media sentiment score of 1.59 beat Bio-Rad Laboratories' score of 1.16 indicating that Veralto is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Veralto
15 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Veralto has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Veralto, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.57B2.62-$1.84B$11.7321.06
Veralto$5.19B5.09$833M$3.5829.76

Veralto has a net margin of 16.65% compared to Bio-Rad Laboratories' net margin of 12.50%. Veralto's return on equity of 41.45% beat Bio-Rad Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories12.50% 4.01% 2.82%
Veralto 16.65%41.45%14.05%

Summary

Veralto beats Bio-Rad Laboratories on 14 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO.B vs. The Competition

MetricBio-Rad LaboratoriesMED IndustryMedical SectorNYSE Exchange
Market Cap$6.72B$3.12B$5.73B$21.51B
Dividend YieldN/A2.36%5.90%3.50%
P/E Ratio21.0621.1675.8629.83
Price / Sales2.62446.35528.7453.44
Price / Cash23.7745.4037.1724.76
Price / Book1.059.6212.794.53
Net Income-$1.84B-$53.28M$3.28B$998.53M
7 Day PerformanceN/A0.31%0.22%1.07%
1 Month PerformanceN/A4.58%4.61%4.41%
1 Year Performance-24.39%9.24%68.33%14.45%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO.B
Bio-Rad Laboratories
N/A$247.05
flat
N/A-13.7%$6.72B$2.57B21.068,200Positive News
VLTO
Veralto
3.4096 of 5 stars
$105.06
-1.7%
$113.43
+8.0%
-2.0%$26.07B$5.19B29.3517,000Positive News
TER
Teradyne
4.5702 of 5 stars
$115.21
-3.1%
$114.44
-0.7%
-13.1%$18.33B$2.82B39.866,500Positive News
FTV
Fortive
4.7536 of 5 stars
$47.68
-0.6%
$62.79
+31.7%
-33.9%$16.13B$6.15B21.4818,000Positive News
RVTY
Revvity
3.9544 of 5 stars
$85.10
-1.4%
$120.07
+41.1%
-31.1%$9.88B$2.76B36.0611,000Analyst Revision
AVTR
Avantor
4.8261 of 5 stars
$12.87
-2.0%
$15.50
+20.5%
-53.9%$8.77B$6.78B12.9913,500Positive News
NVMI
Nova
1.5494 of 5 stars
$277.68
+1.5%
$282.50
+1.7%
+44.9%$8.16B$672.40M37.774,149Short Interest ↑
VNT
Vontier
3.8743 of 5 stars
$42.56
-1.9%
$47.50
+11.6%
+29.1%$6.24B$2.98B16.188,000Positive News
MIR
Mirion Technologies
2.3379 of 5 stars
$22.04
-2.5%
$23.00
+4.3%
+136.0%$5.16B$860.80M734.732,860Analyst Forecast
RAL
Ralliant
2.5856 of 5 stars
$42.29
-0.1%
$55.14
+30.4%
N/A$4.77BN/A0.007,000News Coverage
ST
Sensata Technologies
4.6349 of 5 stars
$31.70
-1.0%
$34.64
+9.3%
-8.1%$4.62B$3.93B42.2619,000Positive News

Related Companies and Tools


This page (NYSE:BIO.B) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners